Related references
Note: Only part of the references are listed.Tumor burden and liver function in HCC patient selection for selective internal radiation therapy: SARAH post-hoc study
Daniel H. Palmer et al.
FUTURE ONCOLOGY (2020)
Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?
Maria Corina Plaz Torres et al.
CANCERS (2020)
Atezolizumab plus Bevacizumab - A Landmark in Liver Cancer
Robin K. Kelley
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Methods for selecting the best evidence to inform a NICE technology appraisal on selective internal radiation therapies for hepatocellular carcinoma
Ros Wade et al.
SYSTEMATIC REVIEWS (2020)
Patient Experience and Preference in Transradial versus Transfemoral Access during Transarterial Radioembolization: A Randomized Single-Center Trial
Lisa B. Liu et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2019)
Same-Day Yttrium-90 Radioembolization: Feasibility with Resin Microspheres
Matthew D. Li et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2019)
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
Jens Ricke et al.
JOURNAL OF HEPATOLOGY (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
Pierce K. H. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Vogel et al.
ANNALS OF ONCOLOGY (2018)
The SIRveNIB and SARAH trials, radioembolization vs. sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future
Carlo Sposito et al.
HEPATOBILIARY SURGERY AND NUTRITION (2018)
Prevention and Treatment of Complications of Selective Internal Radiation Therapy: Expert Guidance and Systematic Review
Bruno Sangro et al.
HEPATOLOGY (2017)
Resin Versus Glass Microspheres for 90Y Transarterial Radioembolization: Comparing Survival in Unresectable Hepatocellular Carcinoma Using Pretreatment Partition Model Dosimetry
Axel Van Der Gucht et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valerie Vilgrain et al.
LANCET ONCOLOGY (2017)
The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres
Fernando Pardo et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres
Derek M. Biederman et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
Jessica Dyson et al.
JOURNAL OF HEPATOLOGY (2014)
A Hepatic Dose-Toxicity Model Opening the Way Toward Individualized Radioembolization Planning
Stephan Walrand et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
How to Define Transarterial Chemoembolization Failure or Refractoriness: A European Perspective
Jean-Luc Raoul et al.
LIVER CANCER (2014)
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma
M. Inarrairaegui et al.
EJSO (2012)
Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
J. P. T. Higgins et al.
RESEARCH SYNTHESIS METHODS (2012)
Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the Radioembolization Brachytherapy Oncology Consortium
Andrew Kennedy et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Share Paper
